Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT04310774
PHASE1/PHASE2

CCRT Followed by Tegafur, Gimeracil and Oteracil Potassium in Cervical Cancer

Sponsor: Peking Union Medical College Hospital

View on ClinicalTrials.gov

Summary

This is a single institute, single-arm, interventional trial to evaluate the efficacy and toxicity of concurrent chemoradiotherapy (CCRT) followed by Tegafur, Gimeracil and Oteracil Potassium Capsules consolidation chemotherapy in patients with locally advanced cervical cancer.

Official title: Concurrent Chemoradiotherapy Followed by Tegafur, Gimeracil and Oteracil Potassium Consolidation Chemotherapy in Patients With Locally Advanced Cervical Cancer: a Single Institute, Prospective, Single-arm Trial

Key Details

Gender

FEMALE

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

200

Start Date

2020-04-15

Completion Date

2026-04-15

Last Updated

2020-03-19

Healthy Volunteers

No

Interventions

DRUG

Tegafur, Gimeracil and Oteracil Potassium Capsules (one drug)

CCRT followed by Tegafur, Gimeracil and Oteracil Potassium Capsules consolidation chemotherapy